KLOW Blend (BPC-157 + TB-500 + GHK-Cu + KPV) | 80mg Lyophilized

$135.00

The KLOW Blend is a four-peptide regenerative research formulation containing BPC-157, GHK-Cu, TB-500, and KPV. This 80mg lyophilized vial extends the classic Wolverine triad with KPV’s anti-inflammatory activity, enabling parallel research across angiogenesis, cell migration, matrix remodeling, and inflammation modulation. HPLC-verified for purity. Strictly for in-vitro laboratory research and development use only; not for human consumption.

116 in stock

Volume pricing
Quantity Unit price Save
1 – 3 $135.00
4+ $110.00 19%

Tier applies automatically at checkout.

Description

KLOW is a four-peptide regenerative blend combining BPC-157, GHK-Cu, TB-500, and KPV. The formulation builds on the classic “Wolverine” triad (BPC-157 + TB-500 + GHK-Cu) with the addition of KPV, a tripeptide noted in research for anti-inflammatory and epithelial barrier activity. Together, these four peptides give researchers a single research candidate spanning angiogenesis, cell migration, extracellular matrix remodeling, and inflammation modulation.

Component Breakdown

  • BPC-157 (Body Protection Compound): A 15-amino acid peptide derived from human gastric juice. Researched for its cytoprotective properties and ability to promote angiogenesis (new blood vessel formation) in damaged tissue models.
  • GHK-Cu (Copper Tripeptide-1): The “Blue Peptide.” Researched for stimulating collagen, elastin, and glycosaminoglycan synthesis, as well as resetting fibroblast gene expression in skin and connective tissue research.
  • TB-500 (Thymosin Beta-4 Fragment): A synthetic fraction of Thymosin Beta-4. Studied for its role in actin sequestration, cell migration, and accelerated wound closure during the repair cascade.
  • KPV (Lys-Pro-Val): A tripeptide fragment of alpha-MSH. Researched for its anti-inflammatory activity, NF-κB pathway modulation, and effects on epithelial barrier integrity in gut and skin models.

The “Synergy” Effect

Each phase of the tissue repair cascade is represented in this blend. BPC-157 drives angiogenesis and cytoprotection at the site of injury; TB-500 promotes the migration of repair cells into the affected area; GHK-Cu directs the structural remodeling of collagen and elastin in the rebuilt matrix; and KPV dampens the inflammatory signaling that can otherwise prolong injury and impair healing. The result is a research blend that allows simultaneous investigation of all four phases in a single protocol.

Quality Assurance

  • Total Mass: 80mg per vial (combined component weight).
  • Purity: ≥98% per component (HPLC verified).
  • Form: Sterile Lyophilized Powder.
  • Storage: Store at -20°C lyophilized; 2–8°C once reconstituted.

FOR RESEARCH USE ONLY:

This product is sold strictly as a chemical reference standard for in-vitro laboratory research purposes only. It is not intended for human or animal consumption, injection, or administration of any kind. This product is not intended to diagnose, treat, cure, or prevent any disease or medical condition. Bodily introduction into humans or animals is strictly prohibited. For use by qualified research professionals only.

Reviews

There are no reviews yet.

Be the first to review “KLOW Blend (BPC-157 + TB-500 + GHK-Cu + KPV) | 80mg Lyophilized”

Your email address will not be published. Required fields are marked *